OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
June 06, 2006
Small molecules are an increasingly viable option for cancer therapeutics
Increased demand for plant-based hormones has spurred Wyeth to ask FDA to set marketing limits on compounded therapies
Medicare Part D has increased drug sales and payers are still trying to hold down costs.